Medical Marijuana in Texas

While the cause of Multiple Sclerosis (MS) is still unknown, this potentially disabling disease triggers the body’s immune system to attack the central nervous system. MS can trigger a wide range of symptoms for patients including muscle spasms, pain, fatigue, slurred speech, dizziness, and anxiety.

Research shows medical marijuana, containing CBD levels equal to or higher than THC, has had positive effects on muscle spasticity and pain. The effects of cannabis and its safety have been reviewed by the American Academy of Neurology in a practice guideline. In Texas, MS is a covered condition eligible for medical marijuana.

MS Symptoms Medical Marijuana Can Relieve:

Muscle spasms

Anxiety

Pain

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects movement and is a covered condition for medical marijuana in Texas. Patients living with Parkinson’s may experience tremors, slowed movements (bradykinesia), rigid muscles, involuntary muscle movements (dyskinesia), impaired posture, spasms, and speech changes. Other associated symptoms can include depression, anxiety, hallucinations, sleep disorders, and late-stage dementia.

Multiple studies in animal models have demonstrated symptom relief, improvement of treatment-induced dyskinesias, and suggest a role in neuroprotection with various cannabinoid therapies. Parkinson’s patients have reported improvements in pain management, movement, spasms, and overall quality of life with cannabis medicine.

Parkinson’s Symptoms Medical Marijuana Can Relieve:

Dyskinesia

Bradykinesia

Muscle spasms

Rigidity

Insomnia

Anxiety

Pain

Peripheral Neuropathy occurs when the nerves outside of the brain and spinal cord are damaged due to traumatic injuries, infections, metabolic problems, and exposure to toxins.

Several clinical studies suggest that patients with Peripheral Neuropathy may benefit from low-dose medical cannabis for pain, insomnia, and overall functioning. As a covered condition, patients diagnosed with Peripheral Neuropathy are eligible for cannabis medicine in Texas.

Peripheral Neuropathy Symptoms Medical Marijuana Can Treat:

Pain

Insomnia

Inflammation

Post-Traumatic Stress Disorder (PTSD) will become a covered condition for medical marijuana in Texas starting September 1, 2021. PTSD is a debilitating neurological condition that develops after experiencing a shocking, scary or dangerous event. The most common symptoms are flashbacks, nightmares, difficulty sleeping, avoidance, cognition, and mood problems.

Research has found that cannabinoids directly affect the brain and central nervous system which may play a role in easing the symptoms of many neurological conditions. Medical marijuana has been shown to reduce PTSD symptoms, sleep disturbances, and nightmares.

PTSD Symptoms Medical Marijuana May Relieve:

Flashbacks

Nightmares

Insomnia

Anxiety

Spasticity is a condition where a person’s muscles stiffen and/or tighten involuntarily, restricting and affecting their ability for normal movement and speech. While it is not a disease or illness unto itself, it is a commonly occurring co-morbidity that accompanies many prevalent muscular and neurological conditions such as Cerebral Palsy, Multiple Sclerosis, Stroke, Encephalitis, ALS, and Meningitis.

Of all the current qualifying conditions listed on the Texas Compassionate Use Act, spasticity has shown the most promise with treatment from medical cannabis. There have been several studies that show a patient suffering from spasticity can find relief from the symptoms of spasticity with CBD and THC treatment. Patients living with Spasticity have reported improvements in pain management, spasms, and sleep while taking medical cannabis.

Spasticity Symptoms Medical Marijuana Can Relieve:

Muscle Spasms

Pain

Insomnia

Anxiety

3-hydroxy-3-methylglutaryl-CoA lyase deficiency

5-aminoimidazole-4-carboxamide ribonucleotide transformylase deficiency

A

Adenylosuccinate synthase Deficiency

Alexander disease

Alpers-Huttenlocher syndrome

ALS (Amyotrophic Lateral Sclerosis)

Alzheimer’s Disease and other dementias

Amyloidoses

Argyrophilic Grain Disease

Aromatic L-amino acid decarboxylase deficiency

Asparylglucosaminuria

Ataxia neuropathy spectrum

Autism and other spectrum disorders

B

Bidirectional enzyme deficiency

Biopterin Defects

C

Canavan disease

Cancer

Central Core

Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy

Cerebral Palsy

Charcot Marie Tooth and related hereditary neuropathies

Childhood Myocerebrohepatopathy spectrum

Congenital Disorders of Glycosylation

Corticobasal Degeneration

Creatine Disorders

Creatine Transporter Defect, also known as SLC 6A8

Creutzfeldt-Jakob Disease

CTE (Chronic Traumatic Encephalopathy)

D

Dementia with Lewy Bodies

Deoxyguanisine kinase deficiency

Dihydropirimidinase Deficiency

Dihydropteridine reductase

Dihydropyrimidine dehydrogenase Deficiency

Duchenne Muscular Dystrophy

E

Epilepsy

F

Facioscapulohumeral Muscular Dystrophy

Familial or Sporadic Fatal Insomnia

Familial Spastic Paraplegia

Farber Disease

Fatty Acid Oxidation

Freidreich’s Ataxia

Frontotemporal dementia and parkinsonism linked to chromosome 17 caused by mutations in MAPT gene

Frontotemporal Lobar Degeneration

G

Galactosemia

Galactosialidosis

Gaucher Type 2 and Type 3

Gerstmann-Straussler-Scheinker Disease

Globular Glial Tauopathy

Glutaric acidemia type 1

Glycine encephalopathy, also known as non-ketotic hyperglycinemia

Glycogen Storage-Lysosomal: Pompe Disease

GM1 gangliosidosis

GM2 gangliosidosis also known as Tay-sachs and Sandhoff Disease

Guanidinoacetate methytransferase deficiency

Guanosine triphosphate cyclohydrolase deficiency

H

Homocysteine re-methylation defects

Huntington’s Disease

Hypoxanthine-guanine phosophoribosyltransferase Deficiency also known as Lesch-Nyhan disease

K

Kearn Sayers Syndrome

Krabbe

Kuru

L

L-2-hydroxyglutaric aciduria

L-Arginine/glycine amidinotransferase deficiency

Leukodystrophy

Lewy Body Disorders

Long-chain L-3 hydroxyacyl-CoA dehydrogenase deficiency

Lysosomal Storage Diseases

M

Mannosidosis

Manosidosis alpha and beta

Maple Syrup Urine Disease

Metachromatic leukodystrophy

Metal Metabolism

Methylenetetrahydrofolate reductase deficiency severe variant

Mitochondrial Conditions

Mitochondrial Depletion syndromes types 1 through 14

Mitochondrial Encephalopathy Lactic Acidosis Stroke

Mitochondrial Encephalopathy Ragged Red Fiber

Mitochondrial neurogastrointestinal encephalopathy

Monoamine oxidase deficiency

Motor Neuron Disease

MS (Multiple Sclerosis)

Mucolipidoses

Mucolipidoses Type II, also known as Inclusion Cell disease

Mucolipidoses Type III, also known as pseudo-Hurler polydystrophy

Mucopolysaccaridosis

Mucopolysaccharidosis Type I, also known as Hurler Syndrome or Scheie Syndrome

Mucopolysaccharidosis Type II, also known as Hunter Syndrome

Mucopolysaccharidosis Type III, also known as Sanfilippo A and B

Mucopolysaccharidosis Type IV, also known as Maroteaux-Lamy

Mucopolysaccharidosis Type VII, also known as Sly

Multiple Sulfatase deficiency

Multiple System Atrophy

Muscular Dystrophies

Myoclonic epilepsy myopathy sensory ataxia

N

Neimann Pick Type A and B

Neimann Pick Type C

Neonatal Adrenoleukodystrophy

Neurodegeneration with brain iron accumulation

Neurofibrillary Tangle dementia, also known as Primary Age-related Tauopathy

Neuronal ceroid lipofuscinosis types 1-10 including Batten Disease

Neuropathy, Ataxia, and Retinitis Pigmentosa

Neurotransmitter defects

O

Oligosaccharidoses

P

Pantothenate Kinase Associated Neurodegeneration

Parkinson’s Disease

Pelizaeus-Merzbacher disease

Peripheral Neuropathies

Peripheral neuropathy types 1 through 4

Peroxisomal biosynthesis defects

Peroxisomal Disorders

Pick Disease

Polymerase G Related Disorders

Polyol disorders

Primary Lateral Sclerosis

Prion Diseases

Progressive Choreas

Progressive dystonias DYT genes 1 through 20

Progressive Muscular Atrophy

Progressive Supranuclear Palsy

Pterin-4-carbinolamine dehydratase

PTSD

Purine and Pyrimidine Defects

Pyruvate Carboxylase Deficiency

Pyruvate Dehydrogenase Deficiency

Pyruvoyl-tetahydropterin synthase

R

Refsum Disease

Respiratory chain disorders complex 1 through 4 defects: Co Q biosynthesis defects

RRM2B-related mitochondrial disease

S

Salidosis

Schindler

Segawa Diease, also known as Dopamine Responsive Dystonia

Sepiapterin reductase

Sialidosis

Spasticity

Sphingolipidoses

Spinal Muscular Atrophy

Spinal-bulbar muscular atrophy

Spinocerebellar ataxia

Subacute necrotizing encephalopathy, also known as Leigh syndrome

SUCLG1-related mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria

Synucleinopathies

T

Tauopathies

Thymidine Kinase

Transactive response DNA-binding protein-43 (TDP-43) Proteinopathies

Trifunctional protein deficiency

V

Vascular dementia

W

Wilson Disease

X

X-linked adrenoleukodystrophy

Z

Zellweger syndrome